Oxidative Stress as Marker of Metabolic Disease - PowerPoint PPT Presentation

1 / 21
About This Presentation
Title:

Oxidative Stress as Marker of Metabolic Disease

Description:

Instruments Required Standard Clinical Chemistry Analyser or Spectrophotometer. Staff Routine Staff Operating Clinical Chemistry Analysers/Spectrophotometers ... – PowerPoint PPT presentation

Number of Views:2095
Avg rating:3.0/5.0
Slides: 22
Provided by: deweta
Category:

less

Transcript and Presenter's Notes

Title: Oxidative Stress as Marker of Metabolic Disease


1
Oxidative Stress as Marker of Metabolic Disease
  • D Alberts
  • Plavolab
  • Development of health products from a natural
    source.

2
Balance
Antioxidants
Oxidants
3
Oxidative Stress
Antioxidants
Oxidants
4
Production of Oxidants
  • Reactive Oxygen Species (ROS)
  • Produced by the body
  • Response to growth factors, cytokines
  • Respiration, phagocytosis
  • Normal Metabolism

5
Antioxidant defenses
  • Enzymatic Mechanisms Superoxide Dismutase (SOD),
    Catalase, Glutathione Peroxidase
  • Exogenous (Dietary) Antioxidants Ascorbate,
    a-Tocopherol, Carotene, Glutathione, Polyphenols
  • Normal Metabolism

6
Production of Oxidants Exceed Natural Defenses
Antioxidants
Oxidants
7
Sources of Excessive oxidants
  • ROS Production Defective Excessive ROS Produced
    - Rheumatoid Arthritis Altered Arachidonic acid
    Metabolism, Inflammatory Bowel Disease, Injury to
    the Central Nervous System, Connective-tissue
    Damage, Inflammation, Diabetes
  • Pollution, Toxic gases, Oxygen excess, Radiation
    Tobacco Smoke, excessive exposure to sunlight
  • Inactivation Endogenous Antioxidants or Reduced
    Intake of Exogenous Antioxidants Poor nutrition

8
DISEASE STATES
  • Cancer
  • Immune System degeneration
  • Neurodegeneration, Stroke
  • Aging, Cataract Formation
  • Diabetes, Obesity
  • Cardiovascular Disease, incl. Hypertension
  • Contribute to 33 Deaths
  • gt40 Total Medical Expenses

9
Carcinogenesis
  • Oxidative DNA Modification
  • High Levels of oxidative lesions
  • Reduced Incidence Populations High Dietary
    Antioxidant Intake

10
Immune System degeneration
  • Free Radicals, Intracellular, required
    Phagocytosis
  • However ! ! !
  • Radicals Leach out of White Cells
  • Extracellular radicals Attack cell Membranes,
    particularly Destruction of Immune Cells, incl.
    Gene Regulation.
  • Reduced Signal Transduction
  • ROS cause Abnormal Cell Proliferation

11
Neurodegeneration
  • Neural Cells Especially Susceptible
  • Alzheimers Disease Key Role in Loss of Neurons
    Mitochondrial Abnormalities - ?Energy
  • Parkinsons Disease Oxidised Dopamine
    Metabolites Toxic to Nigral Neurons
  • Stroke ROS Major Contributor to Damage during
    the Acute Phase.
  • Oxidative stress Major Contributor to
    Pathogenesis of Diabetic Nephropathy

12
Aging and Cataracts
  • Levels of Oxidative Damage Positively Correlated
    with Aging
  • Oxidative Mitochondrial Decay Major Contributor
    to Aging
  • Cataract formation - Amplification of Aging -
    Oxidation Hallmark Age Related Nuclear
    Cataract Cysteine and Methionine Residues
    Oxidised

13
Cardiovascular Disease
  • Atherosclerosis Oxidative Damage to Endothelium
    Oxidation of LDL ? Lipid Plaque Accumulation ?
    Atherosclerosis
  • Hypertension Excessive O2- uncouples Endothelial
    NO Synthase (eNOS) ? Peroxynitrite Vascular
    Dysfunction
  • Endothelial Damage Arteriosclerosis,
    Hypertension, Renal Damage

14
Increase Antioxidant Intake
Antioxidants
Oxidants
15
Increase Antioxidant Intake
  • To Avoid or Minimise these Disease States an
    Increased Antioxidant Intake is Required
  • HOWEVER ! ! !

16
Too High Antioxidant Intake
Oxidants
Antioxidants
17
Too High Antioxidant Intake
  • Reactive Species Required for Normal Metabolism
    and Homeostasis
  • ROS Required for Phagocytosis
  • NOS Required for Endothelial Function Normal
    Blood Pressure

18
A Balance Required
Antioxidants
Oxidants
19
Oxidative Status Monitoring
  • Existing Assays - Specialised Instruments /Staff
  • Expensive to Perform
  • Not Readily Available to Clinicians and/or
    Patient Population
  • Requirement An Easy to Perform, readily
    Available Assay

20
Assay under Development
  • Instruments Required Standard Clinical
    Chemistry Analyser or Spectrophotometer
  • Staff Routine Staff Operating Clinical
    Chemistry Analysers/Spectrophotometers
  • Cost of Assay Very Low Cost Kit Form
  • Accuracy of Assay Being Compared to
    F2-Isoprostane Assay Regarded as Gold
    Standard - Expensive

21
Conclusion
  • Clinicians Aware of Oxidative Stress
  • Weary to treat with Antioxidants Balance
  • Need an Assay to Monitor
  • Clinical Laboratories not Able to Offer this
    Service
  • An Easy to Perform/Low Cost Assay Under
    Development
  • The Assay will lead to an Improved Service by
    Laboratories
Write a Comment
User Comments (0)
About PowerShow.com